TOMAS GANZ, MD
Osteopathic Medicine at Century Blvd, Los Angeles, CA

License number
California G40227
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
5767 W Century Blvd SUITE 200, Los Angeles, CA 90045
Phone
(310) 825-7499
(310) 825-6112

Personal information

See more information about TOMAS GANZ at radaris.com
Name
Address
Phone
Tomas Ganz
168 S Cliffwood Ave, Los Angeles, CA 90049
Tomas Ganz
168 Cliffwood Ave, Los Angeles, CA 90049
Tomas Ganz
1235 Alfred St, Los Angeles, CA 90035

Professional information

Tomas Ganz Photo 1

Chief Medical Officer At Intrinsic Lifesciences Llc Professor At Ucla

Location:
Greater Los Angeles Area
Industry:
Research
Experience:
Intrinsic LifeSciences LLC (Privately Held; 1-10 employees; Biotechnology industry): Chief Medical Officer,  (January 2007-Present) Iron- and anemia-related diagnosticsUCLA (Educational Institution; 10,001+ employees; Research industry): Professor,  (1983-Pre...


Tomas Ganz Photo 2

Tomas Ganz, Los Angeles CA

Specialties:
Internal Medicine, Pulmonary Disease, Critical Care Medicine
Work:
Ucla Chs. 37 055
200 Medical Plz, Los Angeles, CA 90024 Ucla Chs. 37 055
10833 Le Conte Ave, Los Angeles, CA 90095
Education:
University of California at Los Angeles (1978)


Tomas Ganz Photo 3

Competitive Regulation Of Hepcidin Mrna By Soluble And Cell-Associated Hemojuvelin

US Patent:
7534764, May 19, 2009
Filed:
Jun 28, 2006
Appl. No.:
11/427095
Inventors:
Tomas Ganz - Los Angeles CA, US
Lan Lin - Los Angeles CA, US
Yigal P. Goldberg - Vancouver, CA
Assignee:
The Regents of the University of California - Oakland CA
Xenon Pharmaceuticals, Inc. - Burnaby, British Columbia
International Classification:
A61K 38/00
US Classification:
514 12
Abstract:
Disclosed herein are hemojuvelin-specific siRNAs that vary hemojuvelin mRNA concentration. Also disclosed herein, GPI-hemojuvelin positively regulated hepcidin mRNA expression, independently of the IL-6 pathway, whereas soluble hemojuvelin (s-hemojuvelin) suppressed hepcidin mRNA expression in primary human hepatocytes in a log-linear dosedependent manner. Disclosed are compositions and methods for modulating diseases of iron metabolism and hepcidin expression or hepcidin levels.


Tomas Ganz Photo 4

Cationic Oligopeptides Having Microbicidal Activity

US Patent:
4705777, Nov 10, 1987
Filed:
Jun 28, 1985
Appl. No.:
6/750378
Inventors:
Robert I. Lehrer - Santa Monica CA
Michael E. Selsted - Los Angeles CA
Tomas Ganz - Los Angeles CA
Assignee:
The Regents of the University of California - Berkeley CA
International Classification:
A61K 3702, C07K 710
US Classification:
514 12
Abstract:
Novel microbicidal compositions are provided which find use as preservatives, disinfectants, antigens and the like. Particularly, cationic oligopeptides of up to about thirty-five amino acids are provided having amino acid sequences substantially comparable to the amino acid sequences of cationic oligopeptides produced by macrophage. A conserved framework structure is provided.


Tomas Ganz Photo 5

Competitive Regulation Of Hepcidin Mrna By Soluble And Cell-Associated Hemojuvelin

US Patent:
7745407, Jun 29, 2010
Filed:
Mar 4, 2009
Appl. No.:
12/397589
Inventors:
Tomas Ganz - Los Angeles CA, US
Lan Lin - Beijing, CN
Yigal P. Goldberg - Vancouver, CA
Assignee:
The Regents of the University of California - Oakland CA
Xenon Pharmaceuticals Inc. - Burnaby, British Columbia
International Classification:
C12Q 1/68, A61K 38/00
US Classification:
514 12, 435 6
Abstract:
Disclosed herein are hemojuvelin-specific siRNAs that vary hemojuvelin mRNA concentration. Also disclosed herein, GPI-hemojuvelin positively regulated hepcidin mRNA expression, independently of the IL-6 pathway, whereas soluble hemojuvelin (s-hemojuvelin) suppressed hepcidin mRNA expression in primary human hepatocytes in a log-linear dosedependent manner. Disclosed are compositions and methods for modulating diseases of iron metabolism and hepcidin expression or hepcidin levels.


Tomas Ganz Photo 6

Defensin Peptide Compositions And Methods For Their Use

US Patent:
5242902, Sep 7, 1993
Filed:
Sep 6, 1989
Appl. No.:
7/404249
Inventors:
Christopher J. Murphy - Davis CA
Ted W. Reid - Davis CA
Mark J. Mannis - Carmichael CA
Bradley A. Foster - Davis CA
James S. Cullor - Woodland CA
Michael E. Selsted - Los Angeles CA
Robert I. Lehrer - Santa Monica CA
Tomas Ganz - Los Angeles CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 3702, A61K 3700, C07K 710
US Classification:
514 12
Abstract:
A method for treating cutaneous and corneal wounds as well as certain microbial-related diseases comprises topically applying a defensin peptide to the affected tissue. The compositions comprise a natural, synthetic, or analog defensin molecule having both a mitogenic activity capable of stimulating cell growth and an antimicrobial activity capable of inhibiting the growth of a wide variety of pathogens. In addition to therapeutic use, the defensins are useful as mitogens in cell and tissue culture media.


Tomas Ganz Photo 7

Use Of Antimicrobial Proteins And Peptides For The Treatment Of Otitis Media And Paranasal Sinusitis

US Patent:
7985729, Jul 26, 2011
Filed:
Apr 21, 2010
Appl. No.:
12/764852
Inventors:
David J. Lim - Pasadena CA, US
Paul Webster - Pasadena CA, US
Ali Andalibi - Altadena CA, US
Jian-Dong Li - Glendale CA, US
Tomas Ganz - Los Angeles CA, US
Kiweon Cha - Irvine CA, US
Assignee:
House Research Institute - Los Angeles CA
International Classification:
A61P 31/04, A61K 38/17, C07K 14/435
US Classification:
514 24, 514 213, 530300
Abstract:
The pharmaceutical composition and a method of treatment of infectious diseases, such as otitis media, paranasal sinusitis, labyrinthitis and meningitis are described. The composition comprises EP2E or homologues thereof.


Tomas Ganz Photo 8

Competitive Regulation Of Hepcidin Mrna By Soluble And Cell-Associated Hemojuvelin

US Patent:
2010029, Nov 18, 2010
Filed:
May 6, 2010
Appl. No.:
12/775032
Inventors:
TOMAS GANZ - LOS ANGELES CA, US
LAN LIN - BEIJING, CN
YIGAL P. GOLDBERG - VANCOUVER, CA
International Classification:
A61K 38/17, C07K 14/435, G01N 33/68, C12N 15/63, C12N 5/07, A61P 3/00, A61P 3/02
US Classification:
514 212, 530350, 436 86, 4353201, 435325
Abstract:
Disclosed herein are hemojuvelin-specific siRNAs that vary hemojuvelin mRNA concentration. Also disclosed herein, GPI-hemojuvelin positively regulated hepcidin mRNA expression, independently of the IL-6 pathway, whereas soluble hemojuvelin (s-hemojuvelin) suppressed hepcidin mRNA expression in primary human hepatocytes in a log-linear dosedependent manner. Disclosed are compositions and methods for modulating diseases of iron metabolism and hepcidin expression or hepcidin levels.


Tomas Ganz Photo 9

Use Of Antimicrobial Proteins And Peptides For The Treatment Of Otitis Media And Paranasal Sinusitis

US Patent:
2009002, Jan 22, 2009
Filed:
Jul 16, 2008
Appl. No.:
12/174577
Inventors:
David J. Lim - Pasadena CA, US
Paul Webster - Pasadena CA, US
Ali Andalibi - Altadena CA, US
Jian-Dong Li - Glendale CA, US
Tomas Ganz - Los Angeles CA, US
Kiweon Cha - Irvine CA, US
Assignee:
House Ear Institute - Los Angeles CA
International Classification:
C07K 14/00
US Classification:
530324
Abstract:
The pharmaceutical composition and a method of treatment of infectious diseases, such as otitis media, paranasal sinusitis, labyrinthitis and meningitis are described. The composition comprises EP2E or homologues thereof.


Tomas Ganz Photo 10

Mini-Hepcidin Peptides And Methods Of Using Thereof

US Patent:
8435941, May 7, 2013
Filed:
Dec 4, 2009
Appl. No.:
13/131792
Inventors:
Tomas Ganz - Los Angeles CA, US
Elizabeta Nemeth - Los Angeles CA, US
Gloria Preza - Los Angeles CA, US
Piotr Pawel Ruchala - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 38/04
US Classification:
514 54, 514 135, 514 218, 514 217, 514 216
Abstract:
Disclosed herein are peptides which exhibit hepcidin activity and methods of making and using thereof.